Abiopharma

New Form 10-Q - MARAVAI LIFESCIENCES HOLDINGS, INC. Filed: 2025-08-11 AccNo: 0001823239-25-000107 Size: 9 MB

New Form 8-K - Lantheus Holdings, Inc. Filed: 2025-08-11 AccNo: 0001193125-25-178046 Size: 134 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2025

A New Press Release from Oncolytics Biotech, Inc

New Form SCHEDULE 13G/A - Addus HomeCare Corp Filed: 2025-08-11 AccNo: 0000814133-25-000065 Size: 6 KB

Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates

New Form 8-K - BioXcel Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0001104659-25-076214 Size: 214 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - STANDARD BIOTOOLS INC. Filed: 2025-08-11 AccNo: 0000950170-25-106636 Size: 2 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 15-12G - Sage Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0001104659-25-076215 Size: 11 KB

New Form D - INTELLIGENT BIO SOLUTIONS INC. Filed: 2025-08-11 AccNo: 0001493152-25-011815 Size: 12 KB

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

New Form 10-Q - AGENUS INC Filed: 2025-08-11 AccNo: 0000950170-25-106633 Size: 12 MB

New Form SCHEDULE 13G - Neumora Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0000905148-25-002815 Size: 16 KB

New Form 4 - NEUROCRINE BIOSCIENCES INC Filed: 2025-08-11 AccNo: 0000914475-25-000166 Size: 9 KB

Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders